Literature DB >> 6619867

Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations.

V Natarajan, P C Schmid, P V Reddy, M L Zuzarte-Augustin, H H Schmid.   

Abstract

Dog brain homogenates and subcellular preparations incubated in the presence of Ca2+ produced a new phospholipid that was isolated and identified by its infrared spectrum and by chemical degradation as a mixture of 1,2-diacyl, alkenylacyl, and alkylacyl sn-glycero-3-phospho(N-acyl)ethanolamines, 50, 45, and 5%, respectively. The N-acyl groups consisted almost exclusively of 16:0, 18:0, and 18:1 fatty acids. Formation of N-acylethanolamine phospholipids from endogenous substrates was linear for about 90 min at approximately 4.5 nmol/h/mg protein and exhibited a pH optimum of 10. Biosynthetic activity was associated with particulate fractions, primarily microsomes, synaptosomes, and mitochondria, but not with myelin. In each case, small amounts (approximately 0.5 nmol/h/mg protein) of long-chain N-acylethanolamines were also produced. Incubation of dog brain microsomes with 1,2-di[1'-14C]palmitoyl glycerophosphocholine yielded N-acylethanolamine phospholipids labeled at both N-acyl (55%) and O-acyl (45%) moieties. It appears that dog brain organelles may contain a phosphatidylethanolamine N-acyl transferase (transacylase) analogous to that recently demonstrated in the myocardial tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619867     DOI: 10.1111/j.1471-4159.1983.tb00825.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

Authors:  H Cadas; S Gaillet; M Beltramo; L Venance; D Piomelli
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

2.  Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo.

Authors:  Gabriel M Simon; Benjamin F Cravatt
Journal:  Mol Biosyst       Date:  2010-04-14

3.  Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.

Authors:  Yasuo Okamoto; Jun Morishita; Jun Wang; Patricia C Schmid; Randy J Krebsbach; Harald H O Schmid; Natsuo Ueda
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

Review 4.  Lipid-metabolizing serine hydrolases in the mammalian central nervous system: endocannabinoids and beyond.

Authors:  Myungsun Shin; Timothy B Ware; Hyeon-Cheol Lee; Ku-Lung Hsu
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-16       Impact factor: 4.698

Review 5.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

6.  Activation and solubilization by Triton X-100 of membrane-bound phospholipase D of rat brain.

Authors:  H Kanoh; Y Kanaho; Y Nozawa
Journal:  Lipids       Date:  1991-06       Impact factor: 1.880

7.  Identification of N-acylphosphatidylserine molecules in eukaryotic cells.

Authors:  Ziqiang Guan; Shengrong Li; Dale C Smith; Walter A Shaw; Christian R H Raetz
Journal:  Biochemistry       Date:  2007-11-22       Impact factor: 3.162

8.  N-stearoyl-phosphatidylserine: synthesis and role in divalent-cation-induced aggregation and fusion.

Authors:  M Morillo; M L Sagristá; M A de Madariaga
Journal:  Lipids       Date:  1998-06       Impact factor: 1.880

Review 9.  Chemical probes of endocannabinoid metabolism.

Authors:  Jacqueline L Blankman; Benjamin F Cravatt
Journal:  Pharmacol Rev       Date:  2013-03-19       Impact factor: 25.468

Review 10.  Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.

Authors:  Jeannie Hwang; Crista Adamson; David Butler; David R Janero; Alexandros Makriyannis; Ben A Bahr
Journal:  Life Sci       Date:  2009-06-13       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.